Yale Jen
Stock Analyst at Laidlaw & Co.
(0)
# 5060
Out of 5,298 analysts
21
Total ratings
9.09%
Success rate
-42.01%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SLNO Soleno Therapeutics | Maintains: Strong Buy | 75 105 | 72.26 | 45.31% | 2 | Mar 27, 2025 | |
NVCT Nuvectis Pharma | Initiates Coverage On: Buy | 19 | 9.02 | 110.64% | 1 | Mar 17, 2025 | |
LFWD Lifeward | Initiates Coverage On: Buy | 10 | 1.62 | 517.28% | 1 | Feb 10, 2025 | |
ABVX Abivax | Initiates Coverage On: Buy | 48 | 5.85 | 720.51% | 1 | Jul 29, 2024 | |
MEIP MEI Pharma | Downgrades: Hold | n/a | n/a | n/a | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 25 | 0.63 | 3868.25% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 0.59 | 4137.29% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 0.16 | 4587.5% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.1 | 809.09% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 240 | 1.47 | 16226.53% | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 600 | 0.65 | 92207.69% | 1 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 720 | n/a | n/a | 1 | Sep 19, 2017 |